Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT06662526. HopeStage can help you review the study, but cannot decide medical eligibility.
Not Yet RecruitingNCT06662526
Lithium for Prevention of Cognitive Declining in Mood Illnesses
This study is not yet recruiting. It focuses on depression and currently lists study information in Chile.
DepressionOtherFrom 55 Years to 75 Years
Key information made simple
This observational study is looking at how a digital support tool works for people with Dementia, bipolarity, Depression - depression, or Mild Cognitive Impairment in routine care. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment. Taking part may give some people access to a digital support tool with regular follow-up, but direct benefit is not guaranteed.
Your next step
The official record suggests in-person participation through a university, with sites including Instituto Psiquiátrico Dr José Horwitz Barak in Santiago and Psychiatric Institute Dr José Horwitz Barak in Santiago. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include active substance or alcohol problems that could affect the results and safety concerns that need urgent care first. This is a later-stage study, which usually means the approach is being followed in broader real-world use.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- University of Chile
- Sponsor type
- University
- Main activity
- digital app or tool
- Intervention
- Not available
- Time commitment
- long follow-up or multiple visits
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Not Yet Recruiting
- Source
- Official registry link
Key study information
- Official title
- Lithium for Prevention of Cognitive Declining in Mood Illnesses
- Condition
- Dementia; Bipolarity (BD); Depression - Major Depressive Disorder; Mild Cognitive Impairment (MCI)
- Study status
- Not Yet Recruiting
- Sponsor / lead affiliation
- University of Chile
- Location / country
- Chile
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT06662526
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help improve understanding of your condition.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in Chile.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- Lithium for Prevention of Cognitive Declining in Mood Illnesses
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT06662526
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is Lithium for Prevention of Cognitive Declining in Mood Illnesses?
This study is exploring digital app or tool for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by University of Chile. Based on the sponsor name or official registry information, it appears to be a university. You should verify the details in the official registry record.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve digital app or tool, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me